| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Omniab, Inc. (OABI) has 6 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. OABI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.38M | $10.15M | - | |
| Dir | 2.93M | $6.80M | - | |
| Other | 383.6K | $890.0K | - | |
| CFO | 259.4K | $601.8K | - | |
| Dir | 93.3K | $216.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Foehr Matthew W72 | Chief Executive Officer | Buy | 200,000 | $5.05 | $1,010,000.00 | +8.2% | +7.3% | -20.0% | |
| Nov 10, 2023 | Foehr Matthew W72 | President And CEO | Buy | 95,000 | $4.27 | $405,517.00 | +4.1% | +25.2% | +6.6% | |
| Aug 14, 2023 | Foehr Matthew W72 | President And CEO | Buy | 45,000 | $5.48 | $246,600.00 | +2.0% | -18.7% | -21.8% | |
| Jun 9, 2023 | Foehr Matthew W72 | Chief Executive Officer | Buy | 115,000 | $4.52 | $519,800.00 | +4.7% | +18.5% | +2.4% | |
| May 23, 2023 | Higgins John L66 | Director | Sale+OE | 9,000 | $4.05 | $36,450.00 | -0.4% | +34.6% | +2.1% | |
| May 19, 2023 | Higgins John L66 | Director | Sale+OE | 1,000 | $4.05 | $4,050.00 | - | +51.6% | +15.3% | |
| May 18, 2023 | Higgins John L66 | Director | Sale+OE | 50,000 | $3.89 | $194,500.00 | -2.0% | +51.3% | +13.5% | |
| May 12, 2023 | Foehr Matthew W72 | Chief Executive Officer | Buy | 440,000 | $3.40 | $1,496,000.00 | +22.0% | +65.1% | +33.7% | |
| Dec 12, 2022 | Foehr Matthew W72 | President &CEO | Buy | 150,000 | $3.77 | $564,765.00 | +8.9% | -12.2% | +33.9% | |
| Dec 6, 2022 | Cochran Jennifer R.66 | Director | Buy | 22,250 | $3.75 | $83,526.50 | +40.3% | 0.0% | +24.7% |